---
title: "百奧賽圖擬未來 24 個月內斥不超過 5,000 萬回購"
description: "百奧賽圖－B 公佈，未來 24 個月內，擬以不超過 5,000 萬元的內部自有資金購買及或購回 H 股。公司可根據市場狀況及的資本管理需求，註銷有關購回股份或將其作為庫存股份持有，以及用購買 H 股履行股份獎勵。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/244397525.md"
published_at: "2025-06-13T08:35:03.000Z"
---

# 百奧賽圖擬未來 24 個月內斥不超過 5,000 萬回購

> 百奧賽圖－B 公佈，未來 24 個月內，擬以不超過 5,000 萬元的內部自有資金購買及或購回 H 股。公司可根據市場狀況及的資本管理需求，註銷有關購回股份或將其作為庫存股份持有，以及用購買 H 股履行股份獎勵。

百奧賽圖－B(02315.HK) 公佈，未來 24 個月內，擬以不超過 5,000 萬元的內部自有資金購買及或購回 H 股。公司可根據市場狀況及的資本管理需求，註銷有關購回股份或將其作為庫存股份持有，以及用購買 H 股履行股份獎勵。

### Related Stocks

- [02315.HK - 百奧賽圖-B](https://longbridge.com/zh-HK/quote/02315.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Biocytogen Sets Out Board Structure and Committee Roles | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. has announced its board structure, led by Chairman and CEO Dr. Shen Yuelei | [Link](https://longbridge.com/zh-HK/news/275756980.md) |
| Olympics-Ice hockey-Fourth feels like last for Slovakia's Slafkovsky after bronze heartbreak | Slovakia's ice hockey team faced disappointment at the Olympics, finishing fourth after a heavy 6-1 loss to Finland in t | [Link](https://longbridge.com/zh-HK/news/276521032.md) |
| Olympics-Bobsleigh-Germany's Nolte holds nerve to retain Two-Woman title | CORTINA D’AMPEZZO, Italy, Feb 21 (Reuters) - A week after losing the Monobob gold by four hundredths of a second with a  | [Link](https://longbridge.com/zh-HK/news/276519969.md) |
| Olympics-Speed skating-Timeless Bergsma 'not done yet' after striking gold at 40 in Milano Cortina | Jorrit Bergsma, at 40, won his second Olympic gold in speed skating at the Milano Cortina Games, showcasing a remarkable | [Link](https://longbridge.com/zh-HK/news/276519249.md) |
| Tennis-Pegula beats Svitolina in straight sets in Dubai final | Jessica Pegula defeated Elina Svitolina 6-2, 6-4 in the Dubai Tennis Championships final, marking Svitolina's first loss | [Link](https://longbridge.com/zh-HK/news/276517627.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。